Metastatic Medullary Thyroid Carcinoma and Cabozantinib: Case Series and Review of Literature.

about

Metastatic Medullary Thyroid Carcinoma and Cabozantinib: Case Series and Review of Literature.

Item

http://www.wikidata.org/entity/Q47137441

description

2014 nî lūn-bûn

@nan

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Metastatic Medullary Thyroid C ...... ries and Review of Literature.

@en

Metastatic Medullary Thyroid C ...... ries and Review of Literature.

@nl

type

Item

label

Metastatic Medullary Thyroid C ...... ries and Review of Literature.

@en

Metastatic Medullary Thyroid C ...... ries and Review of Literature.

@nl

prefLabel

Metastatic Medullary Thyroid C ...... ries and Review of Literature.

@en

Metastatic Medullary Thyroid C ...... ries and Review of Literature.

@nl

P1476

Metastatic Medullary Thyroid C ...... ries and Review of Literature.

@en

P2093

Han Xiao

http://www.w3.org/2001/XMLSchema#string

Maureen F Zakowski

http://www.w3.org/2001/XMLSchema#string

Meera R Hameed

http://www.w3.org/2001/XMLSchema#string

Miles B Levin

http://www.w3.org/2001/XMLSchema#string

Sakshi Kapur

http://www.w3.org/2001/XMLSchema#string

P2860

Medullary thyroid cancer: monitoring and therapy.

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.

International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1.

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.

Medullary thyroid cancer: management guidelines of the American Thyroid Association.

Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience.

Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables.

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

P304

81-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.14740/WJON779W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29147383

http://www.w3.org/2001/XMLSchema#string

P932

5649879

http://www.w3.org/2001/XMLSchema#string